Nataliya Mar, Daniel P. Petrylak, Christopher J. Hoimes, Jonathan E. Rosenberg, Thomas W. Flaig, Theodore Stewart Gourdin, Pedro C. Barata, Elizabeth Henry, Mehmet Asim Bilen, Saby George, Santosh Rao, Vasileios J. Assikis, Earle F Burgess, Brian E. Lewis, Sandy Srinivas, Seema Rao Gorla, Changting Meng, Yalin Zhu, Peter H. O'Donnell. "Study EV-103 cohort H: Neoadjuvant treatment with enfortumab vedotin (EV) monotherapy in cisplatin (cis)-ineligible patients (pts) with muscle invasive bladder cancer (MIBC)—3-year efficacy results.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.4583